Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
HIKMA PHARMACEUTICALS USA INC. via APCO WORLDWIDE LLC
2026 · third_quarter · Q3
Health and pharmaceutical policies and domestic pharmaceutical manufacturing supply chain issues and drug shortage issues
Trade policies impacting domestic generic pharmaceutical manufacturing
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Source: Senate LDA
2026 · second_quarter · Q2
Trade policies impacting domestic generic pharmaceutical manufacturing
Health and pharmaceutical policies and domestic pharmaceutical manufacturing supply chain issues and drug shortage issues
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HIKMA PHARMACEUTICALS USA INC. via APCO WORLDWIDE LLC
2026 · first_quarter · Q1
Trade policies impacting domestic generic pharmaceutical manufacturing
Health and pharmaceutical policies and domestic pharmaceutical manufacturing supply chain issues and drug shortage issues
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, State, Dept of (DOS)
HIKMA PHARMACEUTICALS USA INC. via APCO WORLDWIDE LLC
2025 · fourth_quarter · Q4
Health and pharmaceutical policies and domestic pharmaceutical manufacturing supply chain issues and drug shortage issues
Trade policies impacting domestic generic pharmaceutical manufacturing
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
HIKMA PHARMACEUTICALS USA INC. via APCO WORLDWIDE LLC
2025 · third_quarter · Q3
Health and pharmaceutical policies and domestic pharmaceutical manufacturing supply chain issues and drug shortage issues
Trade policies impacting domestic generic pharmaceutical manufacturing
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, U.S. Trade Representative (USTR)
HIKMA PHARMACEUTICALS USA INC. via APCO WORLDWIDE LLC
2025 · second_quarter · Q2
Health and pharmaceutical policies and domestic pharmaceutical manufacturing supply chain issues and drug shortage issues
Trade policies impacting domestic generic pharmaceutical manufacturing
Filing targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
HIKMA PHARMACEUTICALS USA INC. via APCO WORLDWIDE LLC
2025 · first_quarter · Q1
Health and pharmaceutical policies and domestic pharmaceutical manufacturing supply chain issues and drug shortage issues
Trade policies impacting domestic generic pharmaceutical manufacturing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE